Toyoda, Yu http://orcid.org/0000-0002-7411-0531
Miyata, Hiroshi
Uchida, Naohiro
Morimoto, Keito
Shigesawa, Ryuichiro
Kassai, Hidetoshi
Nakao, Kazuki
Tomioka, Naoko H.
Matsuo, Hirotaka
Ichida, Kimiyoshi
Hosoyamada, Makoto
Aiba, Atsu
Suzuki, Hiroshi
Takada, Tappei http://orcid.org/0000-0002-3868-9320
Funding for this research was provided by:
The Nakajima Foundation
JSPS KAKENHI (21H03350, 16J01063 and 21K15293, 16H01808, 20H00568, 22K19369, and 22KK0152)
Gout and uric acid foundation of Japan
Takeda Science Foundation
The Nakatomi Foundation
The University of Tokyo
Article History
Received: 8 November 2022
Revised: 20 January 2023
Accepted: 24 January 2023
First Online: 7 February 2023
Declarations
:
: All animal experiments were performed according to methods approved by the Institutional Animal Care and Use Committee of The University of Tokyo. All animals received humane care according to the criteria outlined in the Guide for the Care and Use of Laboratory Animals prepared by the National Academy of Sciences and published by the National Institutes of Health.
: N/A.
: Financial interests: KI and TT received fees for advisory boards and speaking fees from Mochida Pharmaceutical and Fuji Yakuhin. Non-financial interests: dotinurad was kindly provided by Fuji Yakuhin to TT under a material transfer agreement. All the companies had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation. The remaining authors declare they have no relevant financial or non-financial interests to disclose.